Professional Documents
Culture Documents
There are many risk factors which predispose a patient to get Adverse Drug Reactions.
Knowing about these factors will eliminate or reduce the risk of developing the ADRs, by
informing the physician while individualizing the dosage regimen. Although many
susceptibilities are not know, a number of factors which affect susceptibility to ADRs , can
be categories into 3 groups:-
1) Age
Both paediatrics and geriatrics patients are more vulnerable to get ADRs, because of their age
related conditions. Geriatrics patients (≥60 years) are more prone to get ADRs, because of
physiological changes (pharmacokinetics and pharmacodynamic changes) i,e., decline in
metabolism and elimination rate and on multiple drug therapy for age related conditions. As
the age increase the mitigation to preventable ADRs in elderly will become increasingly
important.
Example:-
Paediatrics may develop serious ADRs to some drug when compare to adult, as their system
handling capacity of a drug differ. The organs which participate in drug metabolism and
elimination were not fully developed, due to which they are more prone to ADRs.
Additionally, children are more prone to ADRs because of dosing errors (as there is a
increased number of fixed dose formulation), lack of safety and efficacy.
Example:-
2) Gender
Women are more likely to suffer with ADRs compare to men, because of number of reasons
like physiological and hormonal changes etc. Pregnant women’s are generally at high risk for
ADRS.
3) Race
Certain population from Africa and South East Asia who are deficient in glucose-6-
phosphate-dehydrogenise are more susceptible to get ADRs for certain drugs. Such people
are at substantial risk of developing haemolytic crisis.
Example:-
a) Primaquine induced rapid haemolysis in patients with G6PD deficiency.
4) Genetics
Genetics factors play a major in drug handling and response to a drug, as well as
susceptibility to ADRs in each individual. Based on which a new era of individualisation of
dosage regimen has evolved. As we already know major genetic variations is found in the
cytochrome CYP450 group of isozymes (CYP2D6, CYP2C9, CYP2C19 and CYP3A5).
CYP2C9 accounts for 20% of total hepatic CYP450 content and which leads to a large effect
on metabolism of drugs.
Example:-
5) Ethnicity
Ethnicity also linked to ADRs, due to inherited traits of metabolism. As we already
cytochrome p450 genotype involved in drug metabolism , has varied distribution in different
ethnic groups. ADR susceptibility based of ethnicity could be associated with genetic , but
ethnicity can be argued to be poor marker for a patients genotype.
Example:-
Example:-
1) Polypharmacy
Patients on multiple drug therapy are more susceptible to ADRs, due to alteration in the drug
effects through an interaction mechanism like, synergism and antagonism. Increase in
number of drugs use directly propositional to increased risk of ADRs.
Example:-
Example:-
1) Tobacco use
Smoking increase the enzyme activity in liver and leads to alter in drug metabolisms and
which predispose a patient to ADRs.
Example:-
Example:-
3) Diet
ADRs will also happen when the certain food items along with medicine.
Example:-
a) Grape fruit juice increase the plasma concentration of calcium channel blockers,
when taken together and leads to ADRs.
b) Paracetamol taken with Alcohol causes liver damage.
When a patient uses two systems of medicine together, it predispose a patient ADRs.
Example:-
a) Herbal medicine, st. John’s wort is a enzyme inducer, when taken with cyclosporine,
reduce the effectiveness of cyclosporine.
1. Clinical pharmacy and therapeutics by Roger Walker and Cate Whittlesea: 5th edition;
chapter 5;Churchill livingstone Elsevier; 2012; pg.no 64-67
2. Stephens’ Detection of New Adverse Drug Reactions; john Talbot and Patric Waller;
chapter 2;john wiley & sons,ltd;2004; pn.no 93-107
4. A text book of clinical pharmacy practice: G. Parthasarathi, K.N. Hansen, M.C. Nahata-
Ed-2nd ; chapter 9: universities press; 2012;pg.no 106-107
5. Clinical Pharmacy by HP Tippins and Amrita Bajaj; 2nd edition; chapter 9;career
publications;2011; pg.no 271-272
7. Adverse Drug Reaction by By Stephanie N. Schatz and Robert J. Weber in PSAP 2015 •
CNS/Pharmacy Practice;2015; Pg.no 11-15